Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol

Journal of Lipid Research

Volumn 53, Issue 1, 2012, Pages 137-148

  Potter, Ross M ^a   Harikumar, Kaleeckal G ^a   Wu, S Vincent ^b   Miller, Laurence J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Biological activity; Chimeric receptors; G protein coupled receptors; Perfringolysin; Receptor binding

Indexed keywords

CHOLECYSTOKININ RECEPTOR; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; MEMBRANE LIPID; MEMBRANE PROTEIN; PROTEIN CCK1R; PROTEIN CCK2R; TYPE 1 CHOLECYSTOKININ RECEPTOR; TYPE 2 CHOLECYSTOKININ RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CHO CELL; CONTROLLED STUDY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

ANIMALS; CALCIUM; CELL MEMBRANE; CHO CELLS; CHOLESTEROL; CRICETINAE; HUMANS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B;

EID: 84455191720     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M020065     Document Type: Article

References (62)

1. Brown, D. A., and E. London. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224. (Pubitemid 30430750)
2. Edidin, M. 2001. Shrinking patches and slippery rafts: scales of domains in the plasma membrane. Trends Cell Biol. 11: 492-496. (Pubitemid 33079142)
3. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44: 655-667. (Pubitemid 37279667)
4. Barrantes, F. J. 2010. Cholesterol effects on nicotinic acetylcholine receptor: cellular aspects. Subcell. Biochem. 51: 467-487.
5. Gimpl, G., and F. Fahrenholz. 2000. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur. J. Biochem. 267: 2483-2497. (Pubitemid 30304242)
6. Paila, Y. D., and A. Chattopadhyay. 2009. The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj. J. 26: 711-720.
7. Harikumar, K. G., V. Puri, R. D. Singh, K. Hanada, R. E. Pagano, and L. J. Miller. 2005. Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J. Biol. Chem. 280: 2176-2185.
8. Gimpl, G., K. Burger, and F. Fahrenholz. 1997. Cholesterol as modulator of receptor function. Biochemistry. 36: 10959-10974. (Pubitemid 27396253)
9. Pike, L. J., and L. Casey. 2002. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry. 41: 10315-10322. (Pubitemid 34856457)
10. Pucadyil, T. J., and A. Chattopadhyay. 2004. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. Biochim. Biophys. Acta. 1663: 188-200. (Pubitemid 38625593)
11. Li, H., and V. Papadopoulos. 1998. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 139: 4991-4997. (Pubitemid 28533447)
12. Hanson, M. A., V. Cherezov, M. T. Griffith, C. B. Roth, V. P. Jaakola, E. Y. Chien, J. Velasquez, P. Kuhn, and R. C. Stevens. 2008. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 16: 897-905. (Pubitemid 351778384)
13. Adamian, L., H. Naveed, and J. Liang. 2011. Lipid-binding surfaces of membrane proteins: evidence from evolutionary and structural analysis. Biochim. Biophys. Acta. 1808: 1092-1102.
14. Ondetti, M. A., B. Rubin, S. L. Engel, J. Pluscec, and J. T. Sheehan. 1970. Cholecystokinin-pancreozymin: recent developments. Am. J. Dig. Dis. 15: 149-156.
15. Dufresne, M., C. Seva, and D. Fourmy. 2006. Cholecystokinin and gastrin receptors. Physiol. Rev. 86: 805-847. (Pubitemid 44033383)
16. Cheng, Z. J., K. G. Harikumar, E. L. Holicky, and L. J. Miller. 2003. Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. J. Biol. Chem. 278: 52972-52979.
17. Wu, V., M. Yang, J. A. McRoberts, J. Ren, R. Seensalu, N. Zeng, M. Dagrag, M. Birnbaumer, and J. H. Walsh. 1997. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J. Biol. Chem. 272: 9037-9042. (Pubitemid 27154904)
18. Puri, V., R. Watanabe, M. Dominguez, X. Sun, C. L. Wheatley, D. L. Marks, and R. E. Pagano. 1999. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat. Cell Biol. 1: 386-388. (Pubitemid 129493583)
19. Amundson, D. M., and M. Zhou. 1999. Fluorometric method for the enzymatic determination of cholesterol. J. Biochem. Biophys. Methods. 38: 43-52. (Pubitemid 29050881)
20. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
21. Harikumar, K. G., J. Clain, D. I. Pinon, M. Dong, and L. J. Miller. 2005. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy. J. Biol. Chem. 280: 1044-1050.
22. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85. (Pubitemid 16258399)
23. Flanagan, J. J., R. K. Tweten, A. E. Johnson, and A. P. Heuck. 2009. Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding. Biochemistry. 48: 3977-3987.
24. Heuck, A. P., E. M. Hotze, R. K. Tweten, and A. E. Johnson. 2000. Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol. Cell. 6: 1233-1242.
25. Rossjohn, J., S. C. Feil, W. J. McKinstry, R. K. Tweten, and M. W. Parker. 1997. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell. 89: 685-692. (Pubitemid 27516171)
26. Shimada, Y., M. Maruya, S. Iwashita, and Y. Ohno-Iwashita. 2002. The C-terminal domain of perfringolysin O is an essential cholesterol-binding unit targeting to cholesterol-rich microdomains. Eur. J. Biochem. 269: 6195-6203. (Pubitemid 35461832)
27. Iwamoto, M., I. Morita, M. Fukuda, S. Murota, S. Ando, and Y. Ohno-Iwashita. 1997. A biotinylated perfringolysin O derivative: a new probe for detection of cell surface cholesterol. Biochim. Biophys. Acta. 1327: 222-230. (Pubitemid 27300139)
28. Waheed, A. A., Y. Shimada, H. F. Heijnen, M. Nakamura, M. Inomata, M. Hayashi, S. Iwashita, J. W. Slot, and Y. Ohno-Iwashita. 2001. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc. Natl. Acad. Sci. USA. 98: 4926-4931. (Pubitemid 32397059)
29. Munson, P. J., and D. Rodbard. 1980. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239.
30. Ballesteros, J. A., and H. Weinstein. 1992. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. Biophys. J. 62: 107-109.
31. Rosenbaum, D. M., V. Cherezov, M. A. Hanson, S. G. Rasmussen, F. S. Thian, T. S. Kobilka, H. J. Choi, X. J. Yao, W. I. Weis, R. C. Stevens, et al. 2007. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science. 318: 1266-1273. (Pubitemid 350172885)
32. Miller, L. J., E. L. Holicky, C. D. Ulrich, and E. D. Wieben. 1995. Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity. Gastroenterology. 109: 1375-1380.
33. Miyake, A. 1995. A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon. Biochem. Biophys. Res. Commun. 208: 230-237.
34. Song, I., D. R. Brown, R. N. Wiltshire, I. Gantz, J. M. Trent, and T. Yamada. 1993. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. Proc. Natl. Acad. Sci. USA. 90: 9085-9089. (Pubitemid 23306456)
35. Levitt, E. S., M. J. Clark, P. M. Jenkins, J. R. Martens, and J. R. Traynor. 2009. Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase. J. Biol. Chem. 284: 22108-22122.
36. Niu, S. L., D. C. Mitchell, and B. J. Litman. 2002. Manipulation of cholesterol levels in rod disk membranes by methyl-beta-cyclodextrin: effects on receptor activation. J. Biol. Chem. 277: 20139-20145.
37. Pontier, S. M., Y. Percherancier, S. Galandrin, A. Breit, C. Gales, and M. Bouvier. 2008. Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J. Biol. Chem. 283: 24659-24672.
38. Nguyen, D. H., and D. D. Taub. 2003. Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp. Cell Res. 291: 36-45. (Pubitemid 37338681)
39. Pang, L., M. Graziano, and S. Wang. 1999. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry. 38: 12003-12011.
40. Cherezov, V., D. M. Rosenbaum, M. A. Hanson, S. G. Rasmussen, F. S. Thian, T. S. Kobilka, H. J. Choi, P. Kuhn, W. I. Weis, B. K. Kobilka, et al. 2007. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 318: 1258-1265. (Pubitemid 350172884)
41. Wu, B., E. Y. Chien, C. D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P. Wells, F. C. Bi, et al. 2010. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 330: 1066-1071.
42. Xu, F., H. Wu, V. Katritch, G. W. Han, K. A. Jacobson, Z. G. Gao, V. Cherezov, and R. C. Stevens. 2011. Structure of an agonist-bound human A2A adenosine receptor. Science. 332: 322-327.
43. Chen, Q., G. De Petris, P. Yu, J. Amaral, P. Biancani, and J. Behar. 1997. Different pathways mediate cholecystokinin actions in cholelithiasis. Am. J. Physiol. 272: G838-G844.
44. Yu, P., Q. Chen, P. Biancani, and J. Behar. 1996. Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am. J. Physiol. 271: G56-G61. (Pubitemid 26299726)
45. Amaral, J., Z. L. Xiao, Q. Chen, P. Yu, P. Biancani, and J. Behar. 2001. Gallbladder muscle dysfunction in patients with chronic acalculous disease. Gastroenterology. 120: 506-511. (Pubitemid 32147648)
46. Chen, Q., J. Amaral, P. Biancani, and J. Behar. 1999. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology. 116: 678-685. (Pubitemid 29106776)
47. Chen, Q., J. Amaral, S. Oh, P. Biancani, and J. Behar. 1997. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology. 113: 930-937. (Pubitemid 27381154)
48. Xiao, Z. L., Q. Chen, J. Amaral, P. Biancani, and J. Behar. 2000. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G251-G258. (Pubitemid 30131193)
49. Xiao, Z. L., Q. Chen, J. Amaral, P. Biancani, R. T. Jensen, and J. Behar. 1999. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am. J. Physiol. 276: G1401-G1407. (Pubitemid 29323446)
50. Yu, P., Q. Chen, K. M. Harnett, J. Amaral, P. Biancani, and J. Behar. 1995. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am. J. Physiol. 269: G659-G665.
51. Gáborik, Z., G. Jagadeesh, M. Zhang, A. Spat, K. J. Catt, and L. Hunyady. 2003. The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology. 144: 2220-2228. (Pubitemid 36629870)
52. Ohyama, K., Y. Yamano, T. Sano, Y. Nakagomi, M. Wada, and T. Inagami. 2002. Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A. Biochem. Biophys. Res. Commun. 292: 362-367. (Pubitemid 34694272)
53. Proulx, C. D., B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette, and R. Leduc. 2008. Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor. Mol. Pharmacol. 74: 552-561.
54. Bari, M., N. Battista, F. Fezza, A. Finazzi-Agro, and M. Maccarrone. 2005. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280: 12212-12220.
55. Bari, M., A. Paradisi, N. Pasquariello, and M. Maccarrone. 2005. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells. J. Neurosci. Res. 81: 275-283. (Pubitemid 41153342)
56. Oddi, S., E. Dainese, F. Fezza, M. Lanuti, D. Barcaroli, V. De Laurenzi, D. Centonze, and M. Maccarrone. 2011. Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J. Neurochem. 116: 858-865.
57. Dong, M., G. Liu, D. I. Pinon, and L. J. Miller. 2005. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling. Biochemistry. 44: 6693-6700. (Pubitemid 40593820)
58. Silvente-Poirot, S., and S. A. Wank. 1996. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin. J. Biol. Chem. 271: 14698-14706. (Pubitemid 26194945)
59. Harikumar, K. G., D. I. Pinon, and L. J. Miller. 2006. Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors. J. Biol. Chem. 281: 27072-27080. (Pubitemid 44401736)
60. Roettger, B. F., R. U. Rentsch, E. M. Hadac, E. H. Hellen, T. P. Burghardt, and L. J. Miller. 1995. Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J. Cell Biol. 130: 579-590.
61. Roettger, B. F., R. U. Rentsch, D. Pinon, E. Holicky, E. Hadac, J. M. Larkin, and L. J. Miller. 1995. Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol. 128: 1029-1041.
62. Roettger, B. F., D. I. Pinon, T. P. Burghardt, and L. J. Miller. 1999. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist. Am. J. Physiol. 276: C539-C547. (Pubitemid 29157369)